Cover Image
市場調查報告書

Sealife PHARMA GMBH的產品平台分析

Sealife PHARMA GMBH - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 317365
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Sealife PHARMA GMBH的產品平台分析 Sealife PHARMA GMBH - Product Pipeline Review - 2015
出版日期: 2015年12月23日 內容資訊: 英文 20 Pages
簡介

Sealife PHARMA GMBH是總公司位於奧地利的生物科技企業,正在開發針對多重抗藥性菌感染疾病的治療藥。利用海洋生物的篩檢平台,發現·開發具有生物活性的化合物及物質。

本報告提供Sealife PHARMA GMBH的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Sealife PHARMA GMBH的基本資料

  • Sealife PHARMA GMBH概要
  • 主要資訊
  • 企業資料

Sealife PHARMA GMBH:R&D概要

  • 主要的治療範圍

Sealife PHARMA GMBH:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Sealife PHARMA GMBH:開發中產品概況

  • 初期階段產品開發中產品
    • 臨床試驗前階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Sealife PHARMA GMBH:藥物簡介

  • SLP-0901
  • SLP-0904
  • SLP-0905

Sealife PHARMA GMBH:開發平台分析

  • 各給藥途徑
  • 各分子類型

暫停開發的計劃

Sealife PHARMA GMBH:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07917CDB

Summary

Global Markets Direct's, 'Sealife PHARMA GMBH - Product Pipeline Review - 2015', provides an overview of the Sealife PHARMA GMBH's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sealife PHARMA GMBH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Sealife PHARMA GMBH including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Sealife PHARMA GMBH's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Sealife PHARMA GMBH's pipeline products

Reasons to buy

  • Evaluate Sealife PHARMA GMBH's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Sealife PHARMA GMBH in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Sealife PHARMA GMBH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Sealife PHARMA GMBH and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sealife PHARMA GMBH
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Sealife PHARMA GMBH and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Sealife PHARMA GMBH Snapshot
    • Sealife PHARMA GMBH Overview
    • Key Information
    • Key Facts
  • Sealife PHARMA GMBH - Research and Development Overview
    • Key Therapeutic Areas
  • Sealife PHARMA GMBH - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Sealife PHARMA GMBH - Pipeline Products Glance
    • Sealife PHARMA GMBH - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Sealife PHARMA GMBH - Drug Profiles
    • SLP-0901
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SLP-0904
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SLP-0905
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Sealife PHARMA GMBH - Pipeline Analysis
  • Sealife PHARMA GMBH - Pipeline Products by Route of Administration
  • Sealife PHARMA GMBH - Pipeline Products by Molecule Type
  • Sealife PHARMA GMBH - Dormant Projects
  • Sealife PHARMA GMBH - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Sealife PHARMA GMBH, Key Information
  • Sealife PHARMA GMBH, Key Facts
  • Sealife PHARMA GMBH - Pipeline by Indication, 2015
  • Sealife PHARMA GMBH - Pipeline by Stage of Development, 2015
  • Sealife PHARMA GMBH - Monotherapy Products in Pipeline, 2015
  • Sealife PHARMA GMBH - Preclinical, 2015
  • Sealife PHARMA GMBH - Discovery, 2015
  • Sealife PHARMA GMBH - Pipeline by Route of Administration, 2015
  • Sealife PHARMA GMBH - Pipeline by Molecule Type, 2015
  • Sealife PHARMA GMBH - Dormant Developmental Projects,2015

List of Figures

  • Sealife PHARMA GMBH - Pipeline by Top 10 Indication, 2015
  • Sealife PHARMA GMBH - Pipeline by Stage of Development, 2015
  • Sealife PHARMA GMBH - Monotherapy Products in Pipeline, 2015
  • Sealife PHARMA GMBH - Pipeline by Top 10 Route of Administration, 2015
  • Sealife PHARMA GMBH - Pipeline by Top 10 Molecule Type, 2015
Back to Top